We are live on ! Find out more
CYNA

CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA

Delisted

CYNA was delisted on the 20th of October, 2016.

28 hedge funds and large institutions have $107M invested in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

16% more capital invested

Capital invested by funds: $92.8M → $107M (+$14.7M)

8% more funds holding

Funds holding: 2628 (+2)

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

Holders
28
Holders Change
+2
Holders Change %
+7.69%
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
7
Reduced
9
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
26
Wells Fargo
California
$8K +$8.12K +500 New
Creative Planning
27
Creative Planning
Kansas
$4K +$4.25K +262 New
RCM
28
Riverloft Capital Management
Florida
-$1.22M -75,000 Closed
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
-$912K -55,978 Closed
Alyeska Investment Group
30
Alyeska Investment Group
Illinois
-$244K -15,000 Closed
GL
31
GLG LLC
New York
-$230K -14,111 Closed
Deutsche Bank
32
Deutsche Bank
Germany
-$147K -9,085 Closed
Barclays
33
Barclays
United Kingdom
-$2K -112 Closed
Citigroup
34
Citigroup
New York
+$114 +7 New

CYNA Hedge Fund Activity: Q3 2015 in Review

28 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) for Q3 2015, worth a combined $107M — up 16% from $92.8M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CYNA positions and 7 closed out — a net gain of 2 holders — while 7 added to existing stakes and 9 trimmed.

The largest buyer was Aisling Capital, opening a new position worth an estimated $15.8M. The largest seller was Broadfin Capital, cutting an estimated $4.74M.

  • 28 institutional investors held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) as of Q3 2015, up from 26 in Q2 2015.
  • Funds reported $107M of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) stock for Q3 2015, up 16% quarter-over-quarter.
  • 9 funds opened new CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) positions in Q3 2015 and 7 closed out, a net change of +2 holders.
  • The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) buyer in Q3 2015 was Aisling Capital, an estimated $15.8M added.
  • The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) seller in Q3 2015 was Broadfin Capital, an estimated $4.74M sold.

Based on aggregated 13F filings for Q3 2015.